Update on Preventing Substance-Use Related Infections

Speaker:
Dr. Victoria Weaver
Infectious Diseases Physician, Vancouver General Hospital; Addiction Medicine Physician, St. Paul’s Hospital; Clinical Assistant Professor, Division of Infectious Disease, University of British Columbia
Share this video:
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025